Everett Harris & Co. CA Buys 6,521 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Everett Harris & Co. CA grew its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 16.3% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 46,467 shares of the company’s stock after acquiring an additional 6,521 shares during the quarter. Everett Harris & Co. CA’s holdings in Bath & Body Works were worth $2,006,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Front Row Advisors LLC acquired a new stake in shares of Bath & Body Works during the third quarter worth about $25,000. Trust Co. of Vermont acquired a new stake in shares of Bath & Body Works during the third quarter worth about $27,000. Money Concepts Capital Corp raised its position in shares of Bath & Body Works by 1,180.4% during the fourth quarter. Money Concepts Capital Corp now owns 653 shares of the company’s stock worth $28,000 after purchasing an additional 602 shares during the period. Bruce G. Allen Investments LLC acquired a new stake in shares of Bath & Body Works during the fourth quarter worth about $44,000. Finally, Dark Forest Capital Management LP raised its position in shares of Bath & Body Works by 11,890.0% during the first quarter. Dark Forest Capital Management LP now owns 1,199 shares of the company’s stock worth $44,000 after purchasing an additional 1,189 shares during the period. Institutional investors own 95.14% of the company’s stock.

Analyst Upgrades and Downgrades

BBWI has been the topic of a number of recent research reports. Barclays lowered Bath & Body Works from an “overweight” rating to an “equal weight” rating and lifted their target price for the company from $37.00 to $45.00 in a research report on Thursday, January 4th. UBS Group lifted their target price on Bath & Body Works from $46.00 to $52.00 and gave the company a “neutral” rating in a research report on Monday, March 4th. The Goldman Sachs Group lifted their target price on Bath & Body Works from $49.00 to $56.00 and gave the company a “buy” rating in a research report on Monday, March 4th. BMO Capital Markets lifted their target price on Bath & Body Works from $48.00 to $50.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Finally, Telsey Advisory Group reissued an “outperform” rating and issued a $53.00 target price (up previously from $50.00) on shares of Bath & Body Works in a research report on Thursday, February 29th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Hold” and a consensus target price of $45.80.

Insider Activity at Bath & Body Works

In related news, insider Thomas E. Mazurek sold 4,285 shares of the business’s stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total value of $209,493.65. Following the completion of the sale, the insider now directly owns 45,992 shares in the company, valued at approximately $2,248,548.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.19% of the stock is currently owned by corporate insiders.

Bath & Body Works Trading Up 1.2 %

Shares of NYSE BBWI opened at $50.02 on Friday. Bath & Body Works, Inc. has a 12 month low of $27.30 and a 12 month high of $50.17. The stock has a 50 day moving average of $45.20 and a 200-day moving average of $38.82. The company has a market capitalization of $11.25 billion, a P/E ratio of 12.99, a P/E/G ratio of 1.65 and a beta of 1.85.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, February 29th. The company reported $2.06 EPS for the quarter, topping the consensus estimate of $1.85 by $0.21. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The company had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.84 billion. During the same period in the previous year, the company posted $1.86 EPS. The firm’s revenue for the quarter was up .8% compared to the same quarter last year. Analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 8th. Investors of record on Friday, February 23rd were paid a $0.20 dividend. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $0.80 annualized dividend and a yield of 1.60%. Bath & Body Works’s dividend payout ratio (DPR) is presently 20.78%.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.